new_0222_0603|SNSE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0603|SNSE|1|Sensei Biotherapeutics Inc Total Current Assets (Quarterly) (USD)|Sensei Biotherapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Sensei Biotherapeutics Inc Inventories (Quarterly) (USD)|Sensei Biotherapeutics Inc Net PP&E (Quarterly) (USD)|Sensei Biotherapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Current Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Deposits (Quarterly) (USD)|Sensei Biotherapeutics Inc Book Value (Quarterly) (USD)|Sensei Biotherapeutics Inc Retained Earnings (Quarterly) (USD)|Sensei Biotherapeutics Inc Treasury Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc EV to Revenues|Sensei Biotherapeutics Inc EV to Earnings|Sensei Biotherapeutics Inc EV to Free Cash Flow|Sensei Biotherapeutics Inc EV to Assets (Quarterly)|Sensei Biotherapeutics Inc PS Ratio|Sensei Biotherapeutics Inc PE Ratio|Sensei Biotherapeutics Inc Price to Book Value|Sensei Biotherapeutics Inc PEG Ratio|Sensei Biotherapeutics Inc Debt to Equity Ratio|Sensei Biotherapeutics Inc Dividend Yield|Sensei Biotherapeutics Inc Shareholder Yield (TTM)|Sensei Biotherapeutics Inc Percent of Shares Outstanding Short|Sensei Biotherapeutics Inc Total Receivables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Payables (Quarterly) (USD)|Sensei Biotherapeutics Inc Total Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Return on Invested Capital|Sensei Biotherapeutics Inc Quality Ratio Score|Sensei Biotherapeutics Inc Momentum Score|Sensei Biotherapeutics Inc Beta (1Y)|Sensei Biotherapeutics Inc Sustainable Growth Rate (TTM)|Sensei Biotherapeutics Inc Institutional Investor Ownership Percentage|Sensei Biotherapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Sensei Biotherapeutics Inc Total Employees (Annual)|Sensei Biotherapeutics Inc EPS Diluted (Quarterly) (USD)|Sensei Biotherapeutics Inc Shares Outstanding|Sensei Biotherapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Sensei Biotherapeutics Inc Ordinary Shares Number (Quarterly)|Sensei Biotherapeutics Inc Payout Ratio|Sensei Biotherapeutics Inc Quick Ratio (Quarterly)|Sensei Biotherapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Sensei Biotherapeutics Inc Stock Buybacks (Quarterly) (USD)|Sensei Biotherapeutics Inc Effective Tax Rate (TTM)|Sensei Biotherapeutics Inc Return on Equity|Sensei Biotherapeutics Inc Net Income (TTM) (USD)|Sensei Biotherapeutics Inc Revenue (TTM) (USD)|Sensei Biotherapeutics Inc Dividend Per Share (Quarterly) (USD)|Sensei Biotherapeutics Inc Revenue (Quarterly) (USD)|Sensei Biotherapeutics Inc Gross Profit (Quarterly) (USD)|Sensei Biotherapeutics Inc SG&A Expense (Quarterly) (USD)|Sensei Biotherapeutics Inc Pre-Tax Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Net Interest Income (Quarterly) (USD)|Sensei Biotherapeutics Inc Price (USD)|Sensei Biotherapeutics Inc Total Return Price (USD)|Sensei Biotherapeutics Inc Enterprise Value (USD)|Sensei Biotherapeutics Inc 30-Day Average Daily Volume|Sensei Biotherapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0603|SNSE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0603|SNSE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0603|SNSE|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.4427480916|0|0|0|1.44|0|0|1.4427480916|0|15.347826087|0|183|127.8|0|0|0|0|0|30.6363636364|91.2857142857|92|91.2857142857|27.4|0|127.8|0|0|91.2857142857|91.3333333333|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.44106463878|1.44106463878|1.4427480916|1.44206008584|1.44444444444||
new_0222_0603|SNSE|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|262|0|0|0|225|0|0|262|0|23|0|2|5|0|0|0|0|0|11|7|1|7|10|0|5|0|0|7|6|0|0|4|0|0|0|0|7|7|7|7|263|263|262|233|9||
new_0222_0603|SNSE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0603|SNSE|201912|0.502|0.251||0.268||69.879|21.714|48.165||-68.662|-92.312|||||||||||||||3.547|0|||||||12.3166||-12.4321|||29.5583|||-0.39|||||||||0.982|-6.705|-6.705|-1.396|||||||
new_0222_0603|SNSE|202003||||||||||||||||||||||||||||||||||12.3166||-7.7879||||||-0.4654|0||||||||1.908|-4.692|-4.692|-1.629|||||||
new_0222_0603|SNSE|202006||||||||||||||||||||||||||||||||||12.3166||-7.973||||||-0.3387|0||||||||1.311|-4.91|-4.91|-0.003|||||||
new_0222_0603|SNSE|202009|4.429|3.733||1.05||57.196|4.715|52.481||-51.681|-107.281|||||||||||||||0.974|0|||||||12.3166|25|-8.7151|||29.5583|||-0.4358|0|||-21.674|||||1.788|-5.367|-5.367|-0.003|||||||
new_0222_0603|SNSE|202012|20.076|16.596||1.266||77.871|4.83|73.041||-56.443|-112.412||||-25.8411|||||||0||1.3327||3.882|0||||||24.62|29.5583|32|-3.4718|1.5294||29.5583|||-0.1736||||-20.1|||||2.521|-5.131|-5.131|-0.054|343.8|343.8|509.7787||||
new_0222_0603|SNSE|202103|172.785|169.418||1.655||3.224|2.475|0.749||171.252|-120.384||||-11.6518||||2.5953|||0||1.8685|||0.003||||||43.5154|18.9049||-8.4|1.5294||30.5885|||-0.42|-140.594|||-23.38|||||4.604|-7.972|-7.972|-0.003|246|246|360.2034|10413.2333||266.6|254.8
new_0222_0603|SNSE|202106|165.613|162.498||2.111||4.599|3.923|0.676||163.125|-130.155||||-4.9593||||1.6254|||0||0.7226|||0.003||||||36.5783|30.5885||-6.4|1.5294||30.5885|||-0.3191|0|||-28.241|||||3.886|-9.771|-9.771|0.041|182|182|109.4998|8790.1||143.8|215.6
new_0222_0603|SNSE|202109|158.162|156.662||3.06||6.041|5.264|0.777||155.208|-139.84||||-6.1436||||2.0533|||0||1.7192|||0.003||||||41.6871|30.5885||-6.4|1.5294||30.5885|||-0.3385|0|||-32.559|||||3.873|-9.685|-9.685|0.064|219|219|173.0076|8424.3333||156.6|137.6
new_0222_0603|SNSE|202112||147.621||||6.712|||||||||-0.7738||||1.0428|||0||1.094|||||||||42.6356|||-6|1.5305|||||||||-36.794|||||3.457||-9.366||105.8|105.8|5.1908|5271.4667|-79.3985|97.2|77
new_0222_0603|SNSE|202203||136.224||||14.73|||||||||||||0.4649|||||||||||||||||-8|1.5341|||||||||-41.227|||||5.032||-12.405||44.4|44.4|-79.507|3942.6667||34.2|38
new_0222_0603|SNSE|202206||123.714||||12.12|||||||||||||0.4957|||||||||||||||||-6.8|1.536|||||||||-41.991|||||4.319||-10.535||43.8|43.8|-73.1303|9909.5333||39|38.2
new_0222_0603|SNSE|202209||116.558||||14.817|||||||||||||0.4148|||||||||||||||||-8.8|1.536|||||||||-45.722|||||4.751||-13.416||34|34|-68.942|1455.4||30|27.6
new_0222_0603|SNSE|202212||107.116||||14.968|||||||||||||0.3665|||||||||||||||||-8|1.5382|||||||||-48.588|||||5.703||-12.232||27.2|27.2|-70.7852|2606.9667||27.8|31.4
new_0222_0603|SNSE|202303||95.505||||13.083|||||||||||||0.3954|||||||||||||||||-6.6|1.5486|||||||||-46.36|||||5.804||-10.177||26.4|26.4|-49.047|1950.9||28.6|30
new_0222_0603|SNSE|202306||78.84||||10.379|||||||||||||0.3725|||||||||||||||||-6.2|1.3292||||||7.788|||-45.211|||||5.393||-9.386||26.6|26.6|-60.1775|1151.2||25.6|20.6
new_0222_0603|SNSE|202309||72.013||||10.658|||||||||||||0.2653|||||||||||||||||-5.6|1.2498||||||2.344|||-38.919|||||3.919||-7.124||15.81|15.81|-57.8253|1033.8333||12|14.22
new_0222_0603|SNSE|202312||65.757||||9.479|||||||||||||0.2359|||||||||||||||||-6|1.2515||||||0.252|||-34.101|||||3.649||-7.414||13.916|13.916|-54.6208|2968.1667||16.4|16.8
new_0222_0603|SNSE|202403||58.081||||8.221|||||||||||||0.4018|||||||||||||||||-6.4|1.2537|||||||||-31.916|||||3.813||-7.992||21.8|21.8|-38.4307|3711.9333||19.834|16.98
new_0222_0603|SNSE|202406||52.289||||7.607|||||||||||||0.3127|||||||||||||||||-5.6|1.2562|||||||||-29.672|||||3.203||-7.142||13.298|13.298|-41.4053|11570.7||13.216|12.116
new_0222_0603|SNSE|202409||47.001||||7.475|||||||||||||0.2554|||||||||||||||||-5.8|1.2576|||||||||-29.801|||||3.186||-7.253||11.11|11.11|-38.3171|3274.2333||11.198|10.824
new_0222_0603|SNSE|202412||41.335||||6.975|||||||||||||0.3215|||||||||||||||||-6.2|1.259|||||||||-30.157|||||2.834||-7.77||9.96|9.96|-34.4753|16976.1||9.4|9.32
new_0222_0603|SNSE|202503||34.331||||6.286|||||||||||||0.2977|||||||||||||||||-5.4|1.2604|||||||||-29.029|||||3.549||-6.864||10.166|10.166|-28.5218|4300.2333||7.714|6.18
new_0222_0603|SNSE|202506|||||||||||||||||||0.3337||||||||||||||||||1.2604||||||||||||||||||8.47|8.47|-23.6554|10875.5||9.03|